• 1
    Primary Immunodeficiency Diseases. Report of a WHO Scientific Group WHO. Clin Exp Immunol 1997; 159:6236 41.
  • 2
    Hammarström L & Smith CIE. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs H, Smith CIE, Puck J, eds. Primary immunodeficiency diseases, a molecular and genetic approach. Oxford: Oxford University Press, 1999:250 62.
  • 3
    Hammarström L, Persson MAA, Smith CIE. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA deficient donors. Immunology 1985; 54:821 6.
  • 4
    Oxelius V-A, Laurell AB, Lindqvist B, Henryka G, Axelsson U, Björkander J, Hanson L-Å. IgG subclasses in selective IgA deficiency. Importance of IgG2-IgA deficiency. N Engl J Med 1981; 304:1476 7.
  • 5
    Hammarström L, Grubb R, Jakobsen BK, Oxelius V, Persson U, Smith CIE. Concomitant deficiency of IgG4 and IgE in IgA deficient donors with high titres of anti-IgA. Monogr Allergy 1986; 20:234 5.
  • 6
    Hermaszewski RA & Webster ADB. Primary hypogammaglobulinemia: a survey of clinical manifestations and complications. Quart J Med 1993; 86:31 42.
  • 7
    Cunningham-Rundles C & Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. J Clin Immunol 1999; 92:34 48.
  • 8
    Burrows PD & Cooper MD. IgA deficiency. Adv Immunol 1997; 65:245 76.
  • 9
    Vorechovsky I, Webster ADB, Plebani A, Hammarström L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999; 64:1096 109.
  • 10
    Ishizaka A, Nakanishi M, Yamada S, Sakiyama Y, Matsumoto S. Development of hypogammaglobulinemia in a patient with common variable immunodeficiency. Eur J Pediatr 1989; 149:175 6.
  • 11
    Johnson ML, Keeton LG, Zhu Z-B, Volanakis JE, Cooper MD, Schroeder JR. Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 1997; 108: 477 83.
  • 12
    Espanol T, Catala M, Hernandez M, Caragol I, Bertran JM. Development of a common variable immunodeficiency in IgA deficient patients. Clin Immunol Immunopathol 1996; 80:333 5.
  • 13
    Gutierrez MG & Kirkpatrick CH. Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Allergy 1997; 79:297 301.
  • 14
    Seligmann M, Aucouturier P, Danon F, Preud'homme JL. Changes in serum immunoglobulin patterns in adults with common variable immunodeficiency. Clin Exp Immunol 1991; 84:23 27.
  • 15
    Vorechovsky I, Blennow E, Nordenskjold M, Webster ADB, Hammarstrom L. A putative susceptibility locus on chromosome 18 is not a major contributor to human selective IgA deficiency: evidence from meiotic mapping of 83 multiple-case families. J Immunol 1999; 163: 2236 42.
  • 16
    Lewkonia RM, Gairdner D, Doe WF. IgA deficiency in one of identical twins. BMJ 1976; 1:311 3.
  • 17
    Hammarström L, Lönnqvist B, Ringdén O, Smith CIE, Wiebe T. Transfer of IgA deficiency to a bone marrow grafted patient with aplastic anaemia. Lancet 1985; 1:778 81.
  • 18
    Kurobane I, Riches PG, Sheldon J, Jones S, Hobbs JR. Incidental correction of severe IgA deficiency by displacement bone marrow transplantation. Bone Marrow Transplant 1991; 7:494 5.
  • 19
    Hammarström L, Carlsson B, Smith CIE, Wallin J, Wieslander L. Detection of IgA heavy chain constant region genes in IgA deficient donors: evidence against gene deletions. Clin Exp Immunol 1985; 60:661 4.
  • 20
    Hammarstrom L, Lange G, Smith CIE. IgA2 allotypes in IgA deficiency. Re-expression of the silent IgA2m2 allotype in the children of IgA deficient patients. J Immunogenet 1987; 14:197 202.
  • 21
    Briere F, Bridon J-C, Chevet D, Souillet G, Bienvenu F, Guret C, Martinez-Valdez H, Banchereau J. Interleukin-10 induces B lymphocytes from IgA deficient patients to secrete IgA. J Clin Invest 1994; 94:97 104.
  • 22
    Zielen S, Bauscher P, Hofmann D, Meur SC. Interleukin 10 and immune restoration in common variable immunodeficiency. Lancet 1993; 342:750 1.
  • 23
    Fujieda S, Zhang K, Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cells g subclass-specific isotype switch: switching to γ1, γ3 and γ4, but not g2. J Immunol 1995; 155:2318 28.
  • 24
    Friman V, Hanson LÅ, Bridon J-M, Tarkowski A, Banchereau J, Briere F. IL-10 driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clin Exp Immunol 1996; 104:432 8.
  • 25
    Scott LJ, Bryant A, Webster ADB, Farrant J. Failure in secretion by surface-positive B cells in common variable immunodeficiency (CVID). Clin Exp Immunol 1994; 95:10 13.
  • 26
    Hammarström L, Holm G, Palmblad J, Persson MAA, Smith CIE. Lack of IgG in a healthy adult: a rare case of dysgammaglobulinemia with undetectable serum IgG, IgA2 and IgE. Clin Immunol Immunopathol 1984; 30:1 10.
  • 27
    Engström P-E, Norhagen-Engström G, Bottaro A et al.. Subclass distribution of antigen-specific IgA antibodies in normal donors and individuals with homozygous IgH Cα1 or Cα2 gene deletions. J Immunol 1990; 145:109 16.
  • 28
    Spickett GP, Farrant J, North ME, Zhang J, Morgan L, Webster ADB. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 19:325 8.
  • 29
    North ME, Ivory K, Funauchi M, Webster ADB, Lane AC, Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 1996; 105:517 22.
  • 30
    Farrington M, Grosmaire LS, Nonoyama S et al.. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994; 91:1099 103.
  • 31
    Durandy A, Hivroz C, Mazerolles F et al.. Abnormal CD-40 mediated pathway in B lymphocytes from patients with hyper IgM syndrome and normal CD40-ligand expression. J Immunol 1997; 158:2576 84.
  • 32
    Levy Y, Gupta N, Le Deist F, Fischer A, Weill J-C, Reynaud C-A. Defect in IgV gene somatic hypermutation in common variable immunodeficiency syndrome. Proc Natl Acad Sci USA 1998; 95:13135 40.
  • 33
    Webster ADB & Amlot P. Granulomas in primary immunodeficiency. In: James DG, Zumla A, eds. The granulomatous disorders. Cambridge: Cambridge University Press, 1999:387 98.
  • 34
    Vorechovsky I, Scott D, Haeney MR, Webster ADB. Chromosomal radiosensitivity in common variable immunodeficiency. Mutation Res 1993; 290:255 64.
  • 35
    Kinlen LJ, Webster ADB, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 2:263 6.
  • 36
    Wegner RD, Chrzanowska KH, Sperling K, Stumm M. Ataxia telangiectasia variants (Nijmegen Breakage Syndrome). In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases. A molecular and genetic approach. Oxford: Oxford University Press, 1999:324 34.
  • 37
    Kondratenko I, Amlot PL, Webster ADB, Farrant J. Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. Clin Exp Immunol 1997; 108:9 13.
  • 38
    Spickett GP, Webster ADB, Farrant J. Cellular abnormalities in Common variable immunodeficiency. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. Philadelphia: Harwood Academic Publishers, 1993:111 26.
  • 39
    Fischer MB, Wolf HM, Hauber I, Eggenbauer H, Thon V, Sasgary M, Eibl MM. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26:231 7.
  • 40
    North ME, Webster ADB, Farrant J. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma CD28+ (‘cytotoxic’) CD28( (‘suppresor’) CD8+ subsets. Clin Exp Immunol 1998; 111:70 75.
  • 41
    Iglesias J, Matamoros N, Raga S, Ferrer JM, Mila J. CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis. Clin Exp Immunol 1999; 117:138 46.
  • 42
    Aukrust P, Muller F, Frøland SS. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol 1994; 97:232 8.
  • 43
    Aukrust P, Kristoffersen AK, Müller F, Haug CJ, Espevik T, Frøland SS. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency—possible immunologic and clinical consequences. Blood 1996; 87:674 81.
  • 44
    Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-α-polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997; 159:6236 41.
  • 45
    Webster ADB, Lever A, Spickett G, Beattie R, North M, Thorpe R. Recovery of antibody production after HIV infection in common variable hypogammaglobulinaemia. Clin Exp Immunol 1989; 77:309 13.
  • 46
    Felsburg PJ, Glickman LT, Jezyk PF. Selective IgA deficiency in the dog. Clin Immunol Immunopathol 1985; 36:297 305.
  • 47
    Moroff SD, Hurvitz AI, Peterson ME, Saunders L, Noone KE. IgA deficiency in shar-pei dogs. Vet Immunol Immunopathol 1986; 13:181 8.
  • 48
    Glickman LT, Shofer FS, Payton AJ, Laster LL, Felsburg PJ. Survey of serum IgA, IgG, and IgM concentrations in a large beagle population in which IgA deficiency had been identified. Am J Vet Res 1988; 49:1240 5.
  • 49
    Luster MI, Leslie GA, Cole RK. Selective IgA deficiency in chickens with spontaneous autoimmune thyroiditis. Nature 1976; 263:331.
  • 50
    Hendrickson BA, Conner DA, Ladd DJ et al.. Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J Exp Med 1995; 182:1905 12.
  • 51
    Harriman GR, Bradley A, Das S, Rogers-Fani P, Davis AC. IgA class switch in Iα exon-deficient mice. Role of germline transcription in class switch recombination. J Clin Invest 1996; 97:477 85.
  • 52
    Hendrickson BA, Rindisbacher L, Corthesy B, Kendall D, Waltz DA, Neutra MR, Seidman JG. Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol 1996; 157:750 4.
  • 53
    Lorenz M, Jung S, Radbruch A. Switch transcripts in immunoglobulin class switching. Science 1995; 267:1825 8.
  • 54
    Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S, Bradley A, Zhang Y, Mbawuike IN. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol 1999; 162:2521 9.
  • 55
    Mbawuike IN, Pacheco S, Acuna CL, Switzer KC, Zhang Y, Harriman GR. Mucosal immunity to influenzae without IgA: an IgA knockout mouse model. J Immunol 1999; 162:2530 7.
  • 56
    Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell Immunol 1999; 191:74 80.
  • 57
    Hiroi T, Yanagita M, Iijima H, Iwatani K, Yoshida T, Takatsu K, Kiyono H. Deficiency of IL-5 receptor α-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa associated tissues. J Immunol 1999; 162:821 8.
  • 58
    Banks TA, Rouse BT, Kerley MK et al.. Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995; 155:1685 93.
  • 59
    Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin b deficient mice. Immunity 1997; 6:491 500.
  • 60
    Doi TS, Takahashi T, Taguchi O, Azuma T, Obata Y. NF-kB Rel-A deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med 1997; 185:953 61.
  • 61
    Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D, Sha WC. Cells from p50/NF-kB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 1996; 156:183 91.
  • 62
    Islam KB, Baskin B, Christensson B, Hammarström L, Smith CIE. In vivo expression of human immunoglobulin germ-line mRNA in normal and immunodeficient individuals. Clin Exp Immunol 1994; 95:3 9.
  • 63
    Wang Z, Yunis D, Irigoyen M, Kitchens B, Bottaro A, Alt FW, Alper CA. Discordance between IgA switching at the DNA level and IgA expression at the mRNA level in IgA deficient patients. Clin Immunol 1999; 91:263 70.
  • 64
    Chapel HM & Webster ADB. Assessment of the immune system. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases. A molecular and genetic approach. Oxford: Oxford University Press, 1999:419 31.
  • 65
    Asherson GL & Webster ADB. Diagnosis and treatment of immunodeficiency diseases. London: Blackwell Scientific Publications, 1980:78 98.
  • 66
    Truedsson L, Baskin B, Pan Q, Rabbani H, Vorechovsky I, Smith CIE, Hammarström L. Genetics of IgA deficiency. APMIS 1995; 103:833 42.
  • 67
    Farr M, Kitas GD, Tuhn EJ, Bacon PA. Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis. Br J Rheumatol 1991; 30:413 7.
  • 68
    Hammarström L, Smith CIE, Berg U. Captopril-induced IgA deficiency. Lancet 1991; 336:436.
  • 69
    Maeoka Y, Hara T, Dejima S, Takeshita K. IgA and IgG2 deficiency associated with zonisamide therapy: a case report. Epilepsia 1997; 38:611 3.
  • 70
    Smith CIE & Hammarström L. Immunologic abnormalities induced by D-penicillamine. In: Dukor P, Kallos P, Schlumberger HD, West GB, eds. Pseudoallergic reactions. Involvement of drugs and chemicals 4. Basel: S Karger AG, 1985:138 80.
  • 71
    Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101:1163 74.
  • 72
    Shovlin CL, Simmonds HA, Fairbanks LD et al.. Adult onset immunodeficiency due to inherited adenosine deaminase (ADA) deficiency. J Immunol 1994; 153:2331 9.
  • 73
    Gaspar W & Conley ME. CEI review. 2000; in press.
  • 74
    Conley ME. Autosomal recessive agammaglobulinaemia. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases. A molecular and genetic approach. Oxford: Oxford University Press, 1999:285 91.
  • 75
    Notarangelo LD & Hayward AR. X-linked immunodeficiency with hyper-IgM: biological and clinical aspects. Clin Exp Immunol 2000; in press.
  • 76
    Aittoniemi J, Koskinen S, Laippala P, Laine S, Miettinen A. The significance of IgG subclasses and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency. Clin Exp Immunol 1999; 116:505 8.
  • 77
    Gustafson R, Gardulf A, Granert C, Hansen S, Hammarstrom L. New strategy for prophylactic therapy to patients with ‘selective’ IgA deficiency. Lancet 1997; 350:865.
  • 78
    Bjorkander J, Blake B, Hanson LA. Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Resp Dis 1984; 65:529 36.
  • 79
    Samuelson A, Borelli S, Gustafson R, Hammarstrom L, Smith CIE, Jonasson J, Lindberg AA. Characterisation of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonisation. Scand J Infect Dis 1995; 27:303 13.
  • 80
    Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinaemia. Am J Med 1986; 80:590 4.
  • 81
    Franz A, Webster ADB, Furr PM, Taylor-Robinson D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 1997; 36:661 8.
  • 82
    Rudge P, Webster ADB, Revez T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 1996; 119:1 15.
  • 83
    Webster ADB, Rotbart HA, Warner T, Rudge P, Hyman N. Diagnosis of enterovirus brain disease in hypogammaglobulinaemic patients by polymerase chain reaction. Clin Infect Dis 1993; 17:657 61.
  • 84
    Leen CLS, Bath JCJL, Brettle RP, Yap PL. Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature. Sarcoidosis 1985; 2:91 95.
  • 85
    Smith MS, Webster ADB, Dhillon AP, Dusheiko G, Boulton R, Rolles K, Burroughs AK. Orthotopic liver transplantation for HCV cirrhosis in two patients with common variable hypogammaglobulinaemia. Gastroenterology 1995; 108:879 89.
  • 86
    Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35:1244 9.
  • 87
    Webster ADB. Immunodeficiency and gastrointestinal disease. In: Triger DR, ed. Clinical immunology of the liver and gastrointestinal tract. Bristol: John Wright, 1986:127 49.
  • 88
    Webster ADB, Platts-Mills TAE, Janossy G, Morgan M, Asherson GL. Autoimmune blood dyscrasias in five patients with hypogammaglobulinaemia: response of neutropenia to vincristine. J Clin Immunol 1981; 1:113 8.
  • 89
    Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency. Am J Surg Pathol 1992; 16:1170 82.
  • 90
    Chapel H, Brennan V, Delson E. Immunoglobulin replacement therapy by self-infusion at home. Clin Exp Immunol 1988; 73:160 2.
  • 91
    Gardulf A, Andersen V, Bjorkander J et al.. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and cost. Lancet 1995; 345:365 9.
  • 92
    Bjoro K, Skaug T, Haaland T, Froland SS. Long-term outcome of chronic hepatitis C virus infection in primary immunodeficiency. Quart J Med 1999; 92:433 41.
  • 93
    Kondo N, Takao A, Orii T. Case report: immunoglobulin A deficiency in patients with rheumatoid arthritis treated with aspirin. Biother 1993; 7:59 62.
  • 94
    Murphy EA, Morris AJ, Walker E, Lee FD, Sturrock RD. Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis. J Rheumatol 1993; 20:1397 8.